 Antonius Hendrickx
Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enterococcus faecium | 19 | 2019 | 47 | 5.290 |
Why?
| | Gram-Positive Bacterial Infections | 7 | 2017 | 66 | 2.120 |
Why?
| | Fimbriae, Bacterial | 9 | 2016 | 20 | 2.050 |
Why?
| | Anti-Bacterial Agents | 6 | 2018 | 825 | 1.920 |
Why?
| | Bacterial Proteins | 16 | 2016 | 900 | 1.670 |
Why?
| | Fimbriae Proteins | 6 | 2012 | 14 | 1.540 |
Why?
| | Biofilms | 9 | 2017 | 44 | 1.330 |
Why?
| | Cephalosporins | 2 | 2018 | 42 | 1.320 |
Why?
| | Cross Infection | 6 | 2017 | 193 | 1.060 |
Why?
| | Teichoic Acids | 4 | 2017 | 17 | 1.040 |
Why?
| | Enterococcus | 2 | 2017 | 61 | 1.030 |
Why?
| | Drug Resistance, Multiple, Bacterial | 3 | 2017 | 50 | 0.960 |
Why?
| | Lipopolysaccharides | 4 | 2017 | 278 | 0.940 |
Why?
| | Cell Wall | 6 | 2017 | 62 | 0.910 |
Why?
| | Intestinal Mucosa | 3 | 2018 | 899 | 0.880 |
Why?
| | Immunity, Mucosal | 1 | 2018 | 60 | 0.700 |
Why?
| | Biosynthetic Pathways | 1 | 2017 | 10 | 0.670 |
Why?
| | Drug Synergism | 1 | 2017 | 334 | 0.630 |
Why?
| | Anti-Infective Agents | 1 | 2017 | 109 | 0.620 |
Why?
| | Bacillus cereus | 2 | 2012 | 10 | 0.620 |
Why?
| | Gram-Positive Bacteria | 2 | 2013 | 27 | 0.560 |
Why?
| | Colon | 1 | 2018 | 507 | 0.550 |
Why?
| | Drug Resistance, Bacterial | 2 | 2013 | 80 | 0.520 |
Why?
| | Adhesins, Bacterial | 2 | 2013 | 38 | 0.520 |
Why?
| | Staphylococcus aureus | 5 | 2016 | 293 | 0.500 |
Why?
| | Membrane Proteins | 7 | 2015 | 1212 | 0.490 |
Why?
| | Gene Expression Regulation, Bacterial | 7 | 2015 | 231 | 0.460 |
Why?
| | Aminoacyltransferases | 1 | 2011 | 9 | 0.450 |
Why?
| | Cysteine Endopeptidases | 1 | 2011 | 91 | 0.430 |
Why?
| | Enterococcus faecalis | 3 | 2017 | 51 | 0.410 |
Why?
| | Community-Acquired Infections | 1 | 2010 | 61 | 0.410 |
Why?
| | Bacterial Adhesion | 7 | 2016 | 92 | 0.390 |
Why?
| | Lactobacillus rhamnosus | 3 | 2016 | 15 | 0.380 |
Why?
| | Bacterial Outer Membrane Proteins | 2 | 2014 | 53 | 0.370 |
Why?
| | Organoids | 2 | 2019 | 43 | 0.370 |
Why?
| | Oxidoreductases | 1 | 2008 | 120 | 0.360 |
Why?
| | Microbial Sensitivity Tests | 3 | 2017 | 218 | 0.350 |
Why?
| | Nisin | 2 | 2017 | 3 | 0.320 |
Why?
| | Virulence Factors | 4 | 2015 | 106 | 0.310 |
Why?
| | Mucus | 3 | 2016 | 22 | 0.300 |
Why?
| | Microscopy, Electron, Transmission | 5 | 2015 | 139 | 0.290 |
Why?
| | N-Acetylmuramoyl-L-alanine Amidase | 3 | 2013 | 11 | 0.280 |
Why?
| | Agglutination | 2 | 2015 | 17 | 0.270 |
Why?
| | Molecular Sequence Data | 7 | 2015 | 3198 | 0.260 |
Why?
| | Animals | 15 | 2019 | 27160 | 0.260 |
Why?
| | Genome, Bacterial | 3 | 2010 | 143 | 0.260 |
Why?
| | Probiotics | 2 | 2016 | 76 | 0.260 |
Why?
| | DNA, Bacterial | 4 | 2013 | 272 | 0.250 |
Why?
| | Staphylococcal Infections | 3 | 2016 | 289 | 0.250 |
Why?
| | Calcium | 2 | 2019 | 1237 | 0.240 |
Why?
| | Temperature | 4 | 2015 | 424 | 0.230 |
Why?
| | Multigene Family | 4 | 2012 | 215 | 0.220 |
Why?
| | Sepsis | 3 | 2015 | 303 | 0.220 |
Why?
| | Genomic Islands | 2 | 2011 | 13 | 0.220 |
Why?
| | Membrane Glycoproteins | 3 | 2016 | 437 | 0.220 |
Why?
| | Mice | 9 | 2019 | 11208 | 0.220 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 927 | 0.210 |
Why?
| | Animal Feed | 1 | 2019 | 27 | 0.200 |
Why?
| | Peritoneum | 1 | 2019 | 48 | 0.200 |
Why?
| | Peritoneal Dialysis | 1 | 2019 | 33 | 0.200 |
Why?
| | Genes, Bacterial | 3 | 2012 | 219 | 0.200 |
Why?
| | Peptidoglycan | 3 | 2015 | 30 | 0.190 |
Why?
| | Humans | 23 | 2019 | 84146 | 0.190 |
Why?
| | Fibrinogen | 2 | 2016 | 59 | 0.190 |
Why?
| | Gastrectomy | 1 | 2019 | 60 | 0.190 |
Why?
| | Abdominal Wall | 1 | 2019 | 30 | 0.190 |
Why?
| | Feces | 3 | 2019 | 369 | 0.190 |
Why?
| | Mouth Mucosa | 1 | 2019 | 72 | 0.190 |
Why?
| | Cryptosporidium | 1 | 2018 | 3 | 0.190 |
Why?
| | Cryptosporidiosis | 1 | 2018 | 5 | 0.190 |
Why?
| | Dietary Supplements | 1 | 2019 | 138 | 0.180 |
Why?
| | Gastric Bypass | 1 | 2019 | 105 | 0.180 |
Why?
| | Urethra | 1 | 2018 | 80 | 0.180 |
Why?
| | Penis | 1 | 2018 | 83 | 0.170 |
Why?
| | Depsipeptides | 1 | 2017 | 30 | 0.170 |
Why?
| | Microbial Interactions | 1 | 2016 | 8 | 0.160 |
Why?
| | Staphylococcal Vaccines | 1 | 2016 | 15 | 0.160 |
Why?
| | Osteomyelitis | 1 | 2016 | 54 | 0.160 |
Why?
| | Adaptive Immunity | 1 | 2018 | 163 | 0.160 |
Why?
| | Vancomycin | 1 | 2017 | 94 | 0.160 |
Why?
| | Antibodies, Bacterial | 1 | 2016 | 96 | 0.160 |
Why?
| | Immunoglobulin A, Secretory | 1 | 2015 | 19 | 0.160 |
Why?
| | Mucin-2 | 1 | 2015 | 16 | 0.160 |
Why?
| | Blotting, Western | 4 | 2013 | 834 | 0.160 |
Why?
| | Drug Discovery | 1 | 2017 | 101 | 0.150 |
Why?
| | Uridine Diphosphate N-Acetylmuramic Acid | 1 | 2015 | 1 | 0.150 |
Why?
| | Models, Animal | 1 | 2017 | 272 | 0.150 |
Why?
| | Lipopeptides | 1 | 2015 | 16 | 0.150 |
Why?
| | Microscopy, Atomic Force | 2 | 2013 | 53 | 0.150 |
Why?
| | Prophages | 1 | 2015 | 3 | 0.150 |
Why?
| | Blood Platelets | 1 | 2015 | 151 | 0.150 |
Why?
| | Virus Release | 1 | 2015 | 10 | 0.150 |
Why?
| | Fibronectins | 1 | 2015 | 95 | 0.150 |
Why?
| | Quorum Sensing | 1 | 2015 | 26 | 0.140 |
Why?
| | Endocarditis, Bacterial | 1 | 2015 | 38 | 0.140 |
Why?
| | Cadherins | 1 | 2015 | 148 | 0.140 |
Why?
| | Virulence | 3 | 2011 | 274 | 0.140 |
Why?
| | Ctenocephalides | 1 | 2014 | 1 | 0.140 |
Why?
| | Protein Multimerization | 2 | 2012 | 179 | 0.140 |
Why?
| | Yersinia pestis | 1 | 2014 | 21 | 0.140 |
Why?
| | Immunity, Innate | 1 | 2018 | 433 | 0.130 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2013 | 305 | 0.130 |
Why?
| | Cell Membrane | 1 | 2017 | 691 | 0.130 |
Why?
| | Bacillaceae Infections | 1 | 2012 | 2 | 0.130 |
Why?
| | RNA, Messenger | 3 | 2008 | 2008 | 0.130 |
Why?
| | Polysaccharides, Bacterial | 1 | 2013 | 38 | 0.130 |
Why?
| | Protein Structure, Tertiary | 2 | 2012 | 768 | 0.130 |
Why?
| | Transferases (Other Substituted Phosphate Groups) | 1 | 2012 | 11 | 0.120 |
Why?
| | Small Molecule Libraries | 1 | 2013 | 59 | 0.120 |
Why?
| | Intestines | 1 | 2015 | 428 | 0.120 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1383 | 0.120 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2012 | 94 | 0.120 |
Why?
| | Obesity | 1 | 2019 | 975 | 0.120 |
Why?
| | Bacillus anthracis | 1 | 2012 | 70 | 0.120 |
Why?
| | Collagen | 2 | 2013 | 277 | 0.120 |
Why?
| | Mammals | 1 | 2013 | 168 | 0.110 |
Why?
| | Head and Neck Neoplasms | 1 | 2019 | 1010 | 0.110 |
Why?
| | Protein Subunits | 1 | 2012 | 119 | 0.110 |
Why?
| | Membrane Transport Proteins | 1 | 2012 | 166 | 0.110 |
Why?
| | Protein Sorting Signals | 1 | 2011 | 43 | 0.110 |
Why?
| | Bacterial Vaccines | 1 | 2011 | 42 | 0.110 |
Why?
| | Elapid Venoms | 1 | 2010 | 8 | 0.110 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2010 | 10 | 0.110 |
Why?
| | Molecular Weight | 1 | 2010 | 372 | 0.100 |
Why?
| | RNA, Bacterial | 2 | 2007 | 113 | 0.100 |
Why?
| | Blotting, Southern | 1 | 2009 | 140 | 0.100 |
Why?
| | Ampicillin Resistance | 1 | 2009 | 9 | 0.100 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 675 | 0.100 |
Why?
| | Bacterial Typing Techniques | 1 | 2009 | 41 | 0.100 |
Why?
| | Disease Reservoirs | 1 | 2009 | 21 | 0.100 |
Why?
| | Bacterial Infections | 1 | 2011 | 227 | 0.100 |
Why?
| | Dog Diseases | 1 | 2009 | 41 | 0.100 |
Why?
| | Carrier State | 1 | 2009 | 57 | 0.090 |
Why?
| | Gene Expression | 2 | 2013 | 1341 | 0.090 |
Why?
| | Amino Acid Sequence | 2 | 2010 | 2178 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 2331 | 0.090 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 411 | 0.090 |
Why?
| | Gene Transfer, Horizontal | 1 | 2007 | 33 | 0.090 |
Why?
| | Crystallography, X-Ray | 3 | 2016 | 499 | 0.090 |
Why?
| | Open Reading Frames | 1 | 2007 | 125 | 0.080 |
Why?
| | Mice, Inbred BALB C | 3 | 2015 | 1077 | 0.080 |
Why?
| | Transcription Factors | 1 | 2014 | 1525 | 0.080 |
Why?
| | Proteolysis | 2 | 2016 | 99 | 0.070 |
Why?
| | Hospitals | 1 | 2007 | 211 | 0.070 |
Why?
| | Protein Binding | 3 | 2015 | 1511 | 0.070 |
Why?
| | Adaptation, Physiological | 1 | 2006 | 325 | 0.070 |
Why?
| | Genomics | 1 | 2009 | 655 | 0.070 |
Why?
| | Female | 6 | 2019 | 45020 | 0.060 |
Why?
| | Mutagenesis, Insertional | 2 | 2014 | 114 | 0.060 |
Why?
| | Binding Sites | 2 | 2016 | 1125 | 0.060 |
Why?
| | Microscopy, Immunoelectron | 2 | 2013 | 36 | 0.060 |
Why?
| | Microscopy, Electron | 2 | 2012 | 534 | 0.060 |
Why?
| | Gene Deletion | 2 | 2012 | 347 | 0.050 |
Why?
| | Cloning, Molecular | 2 | 2013 | 684 | 0.050 |
Why?
| | Genetic Variation | 1 | 2007 | 1373 | 0.050 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2019 | 80 | 0.050 |
Why?
| | Cadaver | 1 | 2019 | 186 | 0.050 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 183 | 0.050 |
Why?
| | Mice, SCID | 1 | 2019 | 241 | 0.050 |
Why?
| | Models, Molecular | 2 | 2016 | 1311 | 0.050 |
Why?
| | Base Sequence | 2 | 2015 | 2431 | 0.050 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2019 | 254 | 0.050 |
Why?
| | Species Specificity | 2 | 2011 | 696 | 0.050 |
Why?
| | Carboplatin | 1 | 2019 | 272 | 0.050 |
Why?
| | Organ Culture Techniques | 1 | 2018 | 147 | 0.040 |
Why?
| | Weight Loss | 1 | 2019 | 240 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 465 | 0.040 |
Why?
| | Biodiversity | 1 | 2019 | 209 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2011 | 728 | 0.040 |
Why?
| | Phantoms, Imaging | 1 | 2019 | 428 | 0.040 |
Why?
| | Repetitive Sequences, Amino Acid | 1 | 2016 | 12 | 0.040 |
Why?
| | Cisplatin | 1 | 2019 | 584 | 0.040 |
Why?
| | Models, Biological | 2 | 2018 | 1799 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 206 | 0.040 |
Why?
| | Ultrasonography | 1 | 2019 | 698 | 0.040 |
Why?
| | Bariatric Surgery | 1 | 2019 | 195 | 0.040 |
Why?
| | Chemoradiotherapy | 1 | 2019 | 293 | 0.040 |
Why?
| | Mutation | 3 | 2013 | 3884 | 0.040 |
Why?
| | Protein Stability | 1 | 2016 | 101 | 0.040 |
Why?
| | Laminin | 1 | 2016 | 86 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 418 | 0.040 |
Why?
| | Tryptophan | 1 | 2016 | 87 | 0.040 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2015 | 183 | 0.040 |
Why?
| | Unilamellar Liposomes | 1 | 2015 | 4 | 0.040 |
Why?
| | Antigens, Bacterial | 1 | 2016 | 137 | 0.040 |
Why?
| | Intestine, Small | 1 | 2018 | 344 | 0.040 |
Why?
| | Drug Stability | 1 | 2015 | 69 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2016 | 435 | 0.040 |
Why?
| | Sequence Analysis, DNA | 2 | 2009 | 895 | 0.040 |
Why?
| | Biopsy | 1 | 2019 | 1189 | 0.040 |
Why?
| | Male | 4 | 2019 | 42131 | 0.040 |
Why?
| | Ciprofloxacin | 1 | 2015 | 56 | 0.040 |
Why?
| | Caco-2 Cells | 1 | 2015 | 145 | 0.040 |
Why?
| | Ligands | 1 | 2016 | 431 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2013 | 2317 | 0.040 |
Why?
| | Middle Aged | 3 | 2019 | 25699 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2015 | 318 | 0.030 |
Why?
| | Protein Folding | 1 | 2016 | 291 | 0.030 |
Why?
| | Phylogeny | 2 | 2010 | 1138 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2016 | 483 | 0.030 |
Why?
| | Phosphatidylglycerols | 1 | 2013 | 6 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2013 | 75 | 0.030 |
Why?
| | Cell Fractionation | 1 | 2013 | 74 | 0.030 |
Why?
| | DNA Transposable Elements | 1 | 2014 | 169 | 0.030 |
Why?
| | Drug Resistance, Microbial | 1 | 2013 | 132 | 0.030 |
Why?
| | Acyltransferases | 1 | 2013 | 38 | 0.030 |
Why?
| | Bacterial Capsules | 1 | 2012 | 28 | 0.030 |
Why?
| | Chronic Disease | 1 | 2016 | 977 | 0.030 |
Why?
| | Spores, Bacterial | 1 | 2012 | 17 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2013 | 159 | 0.030 |
Why?
| | Crystallization | 1 | 2013 | 236 | 0.030 |
Why?
| | Microbial Viability | 1 | 2012 | 39 | 0.030 |
Why?
| | Coagulants | 1 | 2011 | 7 | 0.030 |
Why?
| | Lung | 1 | 2018 | 1078 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 944 | 0.030 |
Why?
| | Antithrombins | 1 | 2011 | 12 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2013 | 406 | 0.030 |
Why?
| | Multiprotein Complexes | 1 | 2012 | 94 | 0.030 |
Why?
| | Coagulase | 1 | 2011 | 28 | 0.030 |
Why?
| | von Willebrand Factor | 1 | 2011 | 41 | 0.030 |
Why?
| | Immunization, Passive | 1 | 2011 | 79 | 0.030 |
Why?
| | Longevity | 1 | 2011 | 48 | 0.030 |
Why?
| | Conjugation, Genetic | 1 | 2011 | 21 | 0.030 |
Why?
| | Gastrointestinal Tract | 1 | 2014 | 194 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2012 | 225 | 0.030 |
Why?
| | Bacillus megaterium | 1 | 2010 | 1 | 0.030 |
Why?
| | Protein Transport | 1 | 2012 | 421 | 0.030 |
Why?
| | Antibodies, Neutralizing | 1 | 2011 | 133 | 0.030 |
Why?
| | Stereoisomerism | 1 | 2010 | 101 | 0.030 |
Why?
| | Circular Dichroism | 1 | 2010 | 121 | 0.030 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2010 | 162 | 0.030 |
Why?
| | Gene Transfer Techniques | 1 | 2011 | 160 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2010 | 183 | 0.030 |
Why?
| | Bacteriophages | 1 | 2010 | 50 | 0.030 |
Why?
| | Models, Chemical | 1 | 2010 | 187 | 0.020 |
Why?
| | Adult | 2 | 2019 | 26132 | 0.020 |
Why?
| | Denmark | 1 | 2009 | 14 | 0.020 |
Why?
| | DNA Fingerprinting | 1 | 2009 | 20 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2010 | 324 | 0.020 |
Why?
| | Computational Biology | 1 | 2013 | 534 | 0.020 |
Why?
| | Immunoblotting | 1 | 2009 | 279 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 1960 | 0.020 |
Why?
| | Survival Analysis | 1 | 2013 | 1591 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2011 | 257 | 0.020 |
Why?
| | Myocardium | 1 | 2011 | 555 | 0.020 |
Why?
| | Heart | 1 | 2011 | 536 | 0.020 |
Why?
| | Dogs | 1 | 2009 | 805 | 0.020 |
Why?
| | Rats | 1 | 2015 | 4349 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2011 | 689 | 0.020 |
Why?
| | Protein Conformation | 1 | 2010 | 892 | 0.020 |
Why?
| | Anaerobiosis | 1 | 2006 | 22 | 0.020 |
Why?
| | Aerobiosis | 1 | 2006 | 18 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1826 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2006 | 243 | 0.020 |
Why?
| | Models, Genetic | 1 | 2011 | 924 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2012 | 3200 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2009 | 991 | 0.020 |
Why?
| | Phenotype | 1 | 2011 | 2320 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2009 | 1452 | 0.020 |
Why?
| | Genotype | 1 | 2009 | 1858 | 0.020 |
Why?
| | Aged | 1 | 2016 | 18604 | 0.010 |
Why?
|
|
Hendrickx's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Physical Neighbors People whose addresses are nearby this person. _
|